Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05074472 |
| Title | A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | ZielBio, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mayo Clinic - Phoenix | Phoenix | Arizona | 85054 | United States | Details | |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | United States | Details | |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | United States | Details | |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
| NEXT Oncology | Austin | Texas | 78758 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| University of Virginia | Charlottesville | Virginia | 22908 | United States | Details | |
| NEXT Onoology | Fairfax | Virginia | 22031 | United States | Details |